3//SEC Filing
VBI VACCINES INC. 3
Accession 0001493152-17-004197
CIK 0000704159operating
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 8:51 PM ET
Size
10.6 KB
Accession
0001493152-17-004197
Insider Transaction Report
Form 3
Baxter Jeff
DirectorPresident and CEO
Holdings
Restricted Stock Units (RSUs)
Exercise: $0.00Exp: 2026-06-14→ Common Shares (93,750 underlying)Option (Right to Buy Common Shares)
Exercise: $4.93Exp: 2025-07-30→ Common Shares (156,062 underlying)- 69,005
Common Shares, no par value per share
Option (Right to Buy Common Shares)
Exercise: $5.06Exp: 2019-11-13→ Common Shares (116,420 underlying)Option (Right to Buy Common Shares)
Exercise: $2.50Exp: 2022-03-29→ Common Shares (19,771 underlying)Option (Right to Buy Common Shares)
Exercise: $4.13Exp: 2024-07-25→ Common Shares (392,089 underlying)Option (Right to Buy Common Shares)
Exercise: $2.50Exp: 2022-04-02→ Common Shares (15,306 underlying)
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive 1 common share of the Issuer upon settlement.
- [F2]The RSUs vest 1/3 per year over 3 years, beginning on June 22, 2017, subject to continued service through each vesting date.
- [F3]The option is fully vested.
- [F4]The option vests 1/48th of the total shares monthly following the grant date of July 25, 2014, subject to continued service through each vesting date.
- [F5]The option vests 1/48th of the total shares monthly following the grant date of July 30, 2015, subject to continued service through each vesting date.
Documents
Issuer
VBI VACCINES INC.
CIK 0000704159
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000704159
Filing Metadata
- Form type
- 3
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 8:51 PM ET
- Size
- 10.6 KB